Tessa Niemeyer‐van der Kolk

Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo‐Controlled, Phase II Trial

Tessa Niemeyer‐van der Kolk, Hein van der Wall, G. Hogendoorn et al. · Clinical and Translational Science · 2020 · 44 citations · Full text

Asthma, Drug Hypersensitivity, Antibiotics +15

Topical antimicrobial peptide omiganan recovers cutaneous dysbiosis but does not improve clinical symptoms in patients with mild to moderate atopic dermatitis in a phase 2 randomized controlled trial

Tessa Niemeyer‐van der Kolk, Thomas P. Buters, Lara Krouwels et al. · Journal of the American Academy of Dermatology · 2020 · 40 citations · Full text

Clinical Symptoms, Allergy, Antibiotics +7

A randomized controlled proof‐of‐concept trial of digoxin and furosemide in adults with cutaneous warts

M. Rijsbergen, Tessa Niemeyer‐van der Kolk, G. Hogendoorn et al. · British Journal of Dermatology · 2018 · 37 citations · Full text

Mobile e‐diary application facilitates the monitoring of patient‐reported outcomes and a high treatment adherence for clinical trials in dermatology

M. Rijsbergen, Tessa Niemeyer‐van der Kolk, Rianne Rijneveld et al. · Journal of the European Academy of Dermatology and Venereology · 2019 · 32 citations · Full text

Lesional skin of seborrheic dermatitis patients is characterized by skin barrier dysfunction and correlating alterations in the stratum corneum ceramide composition

Jannik Rousel, Andreea Nădăban, Mahdi Saghari et al. · Experimental Dermatology · 2023 · 27 citations · Full text

Inflammation, Ophthalmology, Lesional Skin +15